SEC 13F Intelligence

Boxer Capital, LLC / APGE

Boxer Capital, LLC’s Apogee Therapeutics Inc Position

Does Boxer Capital, LLC own Apogee Therapeutics Inc (APGE)? Not currently — the last reported position was 179.0K shares worth $11M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$11M
Q3 2024
Shares
179.0K
% of Portfolio
+0.52%
Quarters Held
1
position exited

Position History APGE

Reported value by quarter
Q3 ’24: $11MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024179.0K$11M+0.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of APGE.